FDA Adverse Event Injury Summary report: N

GORE-TEX REGENERATIVE MEMBRANE-TITANIUM REINFORCED

MDR report key: 1511482 · Received October 19, 2009

Report

Report Number
3003910212-2009-00027
Event Type
Injury
Date Received
October 19, 2009
Date of Event
March 31, 2009
Report Date
October 16, 2009
Manufacturer
W.L. GORE & ASSOCIATES,INC
Product Code
NPK
PMA / PMN Number
K960292
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 1

METHOD - DEVICE REMAINS IMPLANTED, REVIEW OF INFORMATION PROVIDED BY THE USER. BASED UPON THE AVAILABLE INFORMATION, THE EXACT CAUSE FOR THE REPORTED EVENT CANNOT BE DETERMINED, BUT THERE IS NO INDICATION THAT A DEVICE DEFECT OR MALFUNCTION WAS INVOLVED. THE POTENTIAL FOR DEVICE EXPOSURE AFTER IMPLANTATION IS ADDRESSED IN THE CAUTIONS SECTION OF THE INSTRUCTIONS FOR USE, STATING, "MATERIAL THAT IS PLACED IN A SUBMERGED APPLICATION SHOULD REMAIN IN PLACE 3 TO 9 MONTHS OR UNTIL BONE REGENERATION IS COMPLETE. HOWEVER, IF EXPOSED, IT IS RECOMMENDED THAT SHORTER TERM REMOVAL (AT APPROX. 4-12 WEEKS) BE ACCOMPLISHED TO AVOID COMPROMISING THE REGENERATIVE RESULT." ADDITIONALLY, THE POST-OPERATIVE REMINDERS INDICATE, "DO NOT ATTEMPT TO COVER MATERIAL THAT HAS BEEN EXPOSED. EXPOSURE OF THE MATERIAL SHOULD NOT INTERFERE WITH REGENERATION IF CLOSELY MONITORED." ALL AVAILABLE INFORMATION HAS BEEN PLACED ON FILE FOR USE IN TRACKING, TRENDING AND FOLLOW UP.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE GORE-TEX REGENERATIVE MEMBRANE BECAME EXPOSED APPROXIMATELY 3 MONTHS AFTER IMPLANTATION FOR GUIDED BONE REGENERATION. THE DENTIST USED A TISSUE GRAFT TO COVER THE EXPOSURE. THE DEVICE REMAINS IMPLANTED, AND IS PLANNED FOR REMOVAL WITHIN 3 MONTHS UPON COMPLETION OF TREATMENT. THE PATIENT IS REPORTED TO BE IN GOOD CONDITION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE-TEX REGENERATIVE MEMBRANE-TITANIUM REINFORCED NPK/BARRIER, SYNTHETIC, INTRAORAL NPK W.L. GORE & ASSOCIATES,INC WLG503

Patients

Seq Age Sex Outcome Treatment
1 45 YR Required Intervention